Overview – Substance-Related & Addictive Disorders, Part 1
A diagnosis of Substance-Related & Addictive Disorders is based on evidence of impaired control, social impairment, risky use, and pharmacological criteria. There is a high prevalence of comorbidity between substance use disorders and other mental illnesses—many areas of the brain are affected by both substance use disorders and other mental illnesses. For example, the Brain Reward System and pathways or circuits that impact decision making, impulse control, and emotions may be affected by addictive substances and disrupted in substance use disorders, depression, schizophrenia, and other psychiatric disorders. Multiple neurotransmitter systems also have been implicated in both substance use disorders and other mental disorders, including dopamine, serotonin, glutamate, GABA, and norepinephrine.
Many different types and classifications of substances produce common short-term effects that may include increased heart rate and high blood pressure, dizziness, tremors, mood changes, and paranoia. In high dosages, the risk increases for heart attack, stroke, respiratory failure, and coma. Long-term substance misuse may lead to immune deficiencies, organ damage, paranoia, and psychosis. Overdose is often a risk as individuals gradually develop tolerance and must increase the dosage or the exposure to achieve the same brain result. Symptoms of an overdose may include agitation, seizures, hallucinations, difficulty breathing, nausea and vomiting, unsteady gait, violent or aggressive behavior, and coma.
Risk factors vary. Emerging consensus is that addictive behaviors result from a combination of 40-60 percent inheritable genetic traits; epigenetics, that includes everything that is not genetics, such as environment, Adverse Childhood Experiences (ACEs), extreme or chronic stress, lifestyle choices, and learned behaviors. In other words, individuals may be at higher risk for addictive behaviors based on genetics and acted upon by epigenetics, with exposure to substances or addictive processes serving as a catalyst for revealing addictive tendencies.
Substance-Related & Addictive Disorders, Part 1, presents information on four types of disorders, one type each day for four days. These are:
Alcohol Use Disorder
Alcohol Use Disorder (AUD) is a highly prevalent, highly disabling, highly comorbid, and relapsing brain disease that often goes untreated in the United States. It is characterized by compulsive alcohol use, uncontrolled dependence on products that contain alcohol, impaired ability to control alcohol intake, and a negative emotional state when not using (sometimes referred to as a “dry drunk”). It is a chronic condition that develops gradually and may last for several years or for a lifetime. It develops when a person ingests alcohol that results in chemical changes in the brain, initially providing a short alcoholic euphoria that makes the person want to drink again, despite the harm that alcohol causes. Some suggest that the euphoria results when the brain recognizes alcohol as a brain toxin and releases dopamine—the feel better chemical—in an attempt to combat it.
Alcohol Use Disorder is among the most prevalent mental disorders worldwide are associated with many physical and psychiatric comorbidities. It contributes substantially to global morbidity and mortality and impairs productivity and interpersonal functioning. It places psychological and financial burdens on the individual’s family, friends, and coworkers; and imposes huge financial burdens on society as a whole through motor vehicle crashes, violence, erratic work history, and property crimes. Only about 19.8 percent of adults with Alcohol Use Disorder are ever treated.
Tobacco Use Disorder
Tobacco Use Disorder or Nicotine Use Disorder is a diagnosis assigned to individuals who are dependent on the psychoactive drug nicotine. A central nervous system (CNS) stimulant, nicotine is found in all tobacco products. It activates the nucleus accumbens, involved with the Brain Reward System. Nicotine has a half-life of about two hours. Nicotine can produce dependence fairly quickly, the onset of craving occurring about one hour after the last dose.
A mild disorder is diagnosed when 2 or 3 symptoms are present. A moderate disorder demonstrates 4-5 symptoms. A severe disorder involves 6 or more symptoms.
Nicotine may be administered through multiple routes. It is important to realize that substituting a different route of administration still continues providing nicotine to the nucleus accumbens, which feeds the addictive behavior. Routes include:
- Inhalation – cigarettes (most common), cigars, pipes
- Buccal – chewing tobacco
- Insufflation – snuff that is usually sniffed or snorted into the nasal cavity
- Vaporizing – electronic mechanisms that vaporize the nicotine
- Gum chewing – use of nicotine gum
- Transdermal – nicotine patches placed on the skin
- Lozenges – place in the mouth
- Spray – nicotine nasal spray
- Inhaler – nicotine inhalers
Cannabis Use Disorder
Cannabis or marijuana is a commonly used drug in the United States. The effects of cannabis are caused by chemical compounds in the cannabis plant, including 400 different cannabinoids such as tetrahydrocannabinol (THC) which allows this drug to have a wide range of health, psychological. and physiological effects on the human body.
Anandamide is an endogenous (internal) cannabinoid neurotransmitter that activates the brain’s cannabinoid receptors CB1 and CB2. When THC enters the bloodstream and reaches the brain, it binds to these cannabinoid receptors. The psychoactive effects of cannabis, known as a “ high “, are subjective and vary among persons and the method of use. Different plants of the genus Cannabis contain different and often unpredictable concentrations of THC and other cannabinoids and hundreds of other molecules that have a pharmacological effect, so that the final net effect cannot reliably be foreseen.
Studies by the National Academies of Sciences have shown that cannabis can be helpful in treating neuropathic pain caused by damaged nerves. More research is needed, however, to determine if marijuana is any better or any worse than other options for managing chronic pain. The downside is that cannabis use can impair cognition and is linked with:
- Memory problems
- IQ level, especially in younger persons
- Impaired depth perception, attention span, and concentration
- Slowed reaction time, decreased muscle strength and hand steadiness
- Symptoms resembling schizophrenia
- Disorientation, unpleasant thoughts, anxiety, and paranoia
- Psychosis, specifically among individuals who carry a particular gene variant
- Decreased energy and motivation
- Increased risk of heart attack, lung cancer, anxiety and depressive disorders
- Suicidal ideation – users have a 50 percent chance of suicidal ideation and are 4 times more likely to attempt suicide compared to nonusers
Gambling Disorder has been identified as an addictive disorder. A specific cause has not been identified. However, it is believed that gambling disorder has a neurobiological basis in common with other addictive disorders. It is characterized by risking money, or valued items, or sometimes behaviors, in the hope of gaining something of greater value. As with other addictive disorders, the individual needs progressively larger amounts of the activity to acquire the same effect that used to be experienced.
A fMRI (functional Magnetic Resonance Imaging) study identified that the Brain Reward System is involved with the reward properties of gambling. Gamblers have cognitive distortions around cause and effect and reward and punishment, which can impel them to continue taking high risk gambling actions even when faced with substantial losses. In addition, problem gambling may be accompanied by cognitive distortions or rigidly held beliefs in superstition, elaborate systems to minimize losses and maximize gains, denial of reality, magical-fantasy thinking that disregards reality, and failure to grasp a very basic concept in gambling—chance events, by definition, cannot be controlled.
Contact us if you would like to receive more information about our mental health services.